Human milk oligosaccharides (HMOs) perform a number of functions including serving as prebiotics to stimulate the growth of beneficial intestinal bacteria, as receptor analogues to inhibit binding of pathogens, and as substances that promote postnatal brain development. There is further evidence that HMOs participate in modulating the human immune system. Because the absorption, catabolism, and biological function of oligosaccharides (OS) have strong correlations with their structures, structure elucidation is key to advancing this research. Oligosaccharides are produced by competing enzymes that provide the large structural diversity and heterogeneity that characterizes this class of compounds. Unlike the proteome, there is no template for oligosaccharides, making it difficult to rapidly identify oligosaccharide structures. In this research, annotation of the neutral free oligosaccharides in milk is performed to develop a database for the rapid identification of oligosaccharide structures. Our strategy incorporates high performance nanoflow liquid chromatography and mass spectrometry for characterizing HMO structures. HPLC-Chip/TOF MS provides a sensitive and quantitative method for sample profiling. The reproducible retention time and accurate mass can be used to rapidly identify the OS structures in HMO samples. A library with 45 neutral OS structures has been constructed. The structures include information regarding the epitopes such as Lewis type, as well as information regarding the secretor status. 
Introduction
Free oligosaccharides (OS) are the third most abundant solid component in human milk after lactose and lipids at about 7-12 g/L in mature milk. [1] [2] [3] [4] The studies of human milk oligosaccharides (HMOs) indicate that nutrients are not the only benefits the infants get from their mothers' milk. The use of defatted HMOs increased the platelet-neutrophil complexes (PNCs) levels. 2 HMOs are involved in intestinal absorption and renal excretion that may also enhance the mineralabsorptionandpromotethepostnatalbraindevelopment. 2, 5, 6 In addition, by binding to certain pathogenic microorganisms, HMOs can inhibit the adherence of pathogens with epithelial cell surface glycans and therefore limit the virulence of some pathogens. 2, [6] [7] [8] [9] HMOs with specific epitopes inhibit the adhesion of certain microorganisms such as Escherichia coli, Pneumococci, and Vibrio cholerae with receptors. This lowers the risk for newborn infants of getting diseases such as diarrhea, otitis media, and meningitis. 2, 6 HMOs also serve as prebiotics by stimulating the growth of beneficial intestinal bacteria such as bifidobacteria and lactobacilli (probiotics) in neonates. 2, [4] [5] [6] 10, 11 The development of balanced intestinal microflora may play an important role for modulating the postnatal immune system. 2, 6 The large diversity of structures suggests a multitude of functions. Absorption, catabolism, and biological functions of OS all correlate with structures. 2, 6, 12 Thus, knowledge of HMO structures is essential for determining biological functions. Shown in Figure 1a is the structure of a common milk oligosaccharide (right structure) along with the monosaccharide symbolic structures (left structure). The structures of HMOs start with the glucose (Glc) at the reducing end and a 1-4 galactose (Gal) bound to the glucose to form a lactose core. Attached to the core structure N-acetylglucosamine (GlcNAc) is a 1-3 linkage leading to a linear chain (right structure, Figure 1b ). When two GlcNAc are added on both the 1-3 and 1-6 positions, it leads to a branched chain (left structure, Figure 1b ). After addition of the GlcNAc, another galactose is added either at 1-4 or 1-3. The resulting N-acetylglucosamine and galactose disaccharide may repeat as many as 25 times. The structures for HMOs can be further diversified by fucosylation and sialylation on vital positions. 7 Fucosylation on the reducing end always yields Fuc(R1-3), whereas on the nonreducing end the Fuc(R1-2) is dominant, which is found in secretors. 12 Another Lewis gene-dependent fucosyltransferase forms either R1-3 or R1-4 fucose on GlcNAc. Sialylation occurs on the nonreducing terminal attaching either R2-3 or R2-6 sialic acid (NeuAc) to galactose, whereas on GlcNAc it forms only R2-6 linkages (Figure 1b) . 7, 13 Numerous techniques have been used to analyze the structures of HMOs including high performance liquid chromatography (HPLC), high pH anion-exchange chromatography (HPAEC), and capillary electrophoresis (CE) for sample separation and nuclear magnetic resonance (NMR) and mass spectrometry (MS) for structure characterization. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] So far, more than 200 oligosaccharides from human milk have been reported and more than 90 different oligosaccharide structures have been published. 7, [27] [28] [29] However, those who want to study milk OS need to repeat the complicated sample separation and timeconsuming data analysis to confirm the HMO structures in their own samples.
In this research, an oligosaccharide library is constructed on the basis of the retention times and accurate masses obtained from nano-LC coupled to MS in order to provide a facile and sensitive method for identifying OS structures from biological mixtures. [30] [31] [32] The instrument employs microchip-based nanoLC technology with a column packed with porous graphitized carbon (PGC). [33] [34] [35] An orthogonal time-of-flight (TOF) mass spectrometer is used as the detector and coupled to the nano-LC via nano electrospray ionization (nano-ESI). Structural analysis is also performed by MALDI FTICR-MS with collision induced dissociation (CID) [36] [37] [38] and infrared multiphoton dissociation (IRMPD). [39] [40] [41] Together with controlled exoglycosidase digestion, the specific linkages between monosaccharides were elucidated. 42, 43 Because the retention time (RT) is highly reproducible on the HPLC-Chip/TOF MS, the oligosaccharide structures from milk samples can be rapidly identified by simply matching the retention times and accurate masses from the library. 27 ,44 
Experimental Section
Reagents and Materials. OS were extracted from human milk obtained from the milk banks in San Jose, CA and Austin, TX. The extraction method was the same as in our previous publication. 27, 45 Sodium borohydride (98%) and 2,5-dihydroxybenzoic acid (DHB) were purchased from Sigma-Aldrich (St. Louis, MO). Nonporous graphitized carbon cartridges (GCC, 150 mg bed weight, 4 mL cartridge volume) were bought from Alltech (Deerfield, IL). Standard HMOs were purchased from Dextra Laboratories (Earley Gate, U.K.). R(1-2)-Fucosidase was from EMD Calbiochem (La Jolla, CA). (1-3)-Galactosidase was from New England Biolab (Beverly, MA). (1-4)-Galactosidase was from ProZyme (San Leandro, CA). R(1-3,4)-Fucosidase was from Sigma-Aldrich (St. Louis, MO). All other reagents were of analytical or HPLC grade.
Oligosaccharide Reduction and Purification. The extracted HMOs (50 mg in 250 µL of deionized water) were reduced by 250 µL of 2.0 M sodium borohydride in a water bath at 42°C for 17 h. The reaction product was desalted and purified by solid phase extraction (SPE) using GCC. 46 Prior to use, the GCC was conditioned by 6 mL of 80% acetonitrile (ACN) in water (v/v) with 0.1% trifluoroacetic acid (TFA, v/v) and then 6 mL of deionized water. After loading the OS sample on the GCC, the cartridges were washed with 2.5 mL of deionized water for 8 times to remove the salts. The OS were eluted with 6 mL of 20% ACN in water (v/v) and 6 mL of 40% ACN in water (v/v) with 0.05% TFA. After the GCC fractions were combined, the sample was dried in vacuo and reconstituted with nanopure water before MS analysis.
HPLC-Chip/TOF MS Analysis. The pooled HMOs sample was analyzed by an Agilent 6200 HPLC-Chip/TOF MS instrument (Agilent Technologies, Santa Clara, CA) equipped with a capillary pump as the loading pump for sample enrichment, a nanopump as the analytical pump for sample separation, a microwell-plate autosampler maintained at 6°C by the ther- Nineteen standard milk OS obtained from commercial sources were reduced and introduced into the HPLC-Chip/TOF under identical conditions. The reproducibility of the LC retention time is excellent and typically less than 5 s on samples run on the same days. The mass error is less than 5 ppm. The corresponding structures in the milk pool were determined by matching the retention times and accurate masses against the standards.
Separation of HMOs by HPLC. The reduced HMOs were separated on an Agilent Hewlett-Packard Series 1100 HPLC instrument with Hypercarb PGC column (100 mm × 2.1 mm, 5 µm particle size, Thermoquest, Hypersil Division) detected at 206 and 254 nm. Analyze HPLC Fractions by MALDI FTICR. The HiRes MALDI FTICR (IonSpec, Irvine, CA) has an external MALDI source with a pulsed 355 nm Nd:YAG laser, a hexapole ion guide, an ultrahigh vacuum system maintained by two turbo pumps, one cryopump, and a 7.0 T shielded superconducting magnet. DHB was used as matrix (8 mg/160 µL in 50% ACN/ water (v/v)) in both positive and negative modes. The HMOs solution (0.5 µL) was spotted on a 100-sample stainless steel probe followed by adding 0.25 µL of 0.01 M NaCl solution as a cation dopant and 0.5 µL of matrix solution. In the negative mode experiment, no NaCl solution was added. The sample was dried in the vacuum chamber before putting into the ion source.
The IRMPD was performed to examine the structures for HMOs. The precursor ion was isolated in the ICR cell by using the arbitrary-waveform generator and the frequency synthesizer. A continuous-wave Parallax CO 2 laser (10.6 µm wavelength) was used for photon dissociation as described in previous publications. [39] [40] [41] CID was also performed by sustained off resonance irradiation (SORI) using an arbitrary waveform generator. The precursor ion was excited at about 1000 Hz higher than its cyclotron frequency for 1000 ms at 2-8 V. The collision energy was adjusted according to the size of the OS and the degree of fragmentation.
Exoglycosidase Digestion. The detailed procedure and condition for digestion was reported in previous publications. 42, 43 Typically, buffer solutions were prepared by adding the glacial acetic acid into the 0.1 M ammonium acetate solution until the specific pH value was reached. For certain enzymes, the commercial buffer with the package was used directly for the digestion. 1 µL enzyme solution was added into 1 µL oligosaccharide solution with another 3 µL buffer solution and incubated at 37°C for certain periods of time depending on the types of enzyme used. The mole ratio of the protein to oligosaccharides is approximately 1:100-200, and varies according to the concentrations of the enzyme provided by different manufacturers. The volume of enzyme added can be changed based on the concentration of the OS sample. The only complication is when an R-fucose is adjacent to a -galactose, which blocks the release of the -galactose due to steric hindrance. 42 The R-fucosidase needs to be applied first before further digestion with the -galactosidase. -galactose without the adjacent R-fucose is referred to as a "free galactose" in the following discussion. The workflow for elucidating the structures is shown in Supplementary Figure 1 .
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Results and Discussion
MALDI MS Analysis of Reduced HMOs. The reduced HMOs were initially analyzed by MALDI FTICR-MS. In the positive mode (Supplementary Figure 2a) the spectrum showed mainly the sodiated ions for reduced neutral HMOs (2.0 Da larger than nonreduced HMOs). The compositions were calculated using an in-house software "oligosaccharide calculator" written in Igor (using a mass accuracy of less than 5 ppm). The ions generated by anionic OS were suppressed by neutral OS in the positive mode. However, the negative ion mode spectrum (Supplementary Figure 2b) gives stronger signals for anionic OS. The results from the MALDI showed that most of the HMOs are fucosylated with up to five fucoses. Most of the anionic HMOs contain only a single sialic acid (N-acetylneuraminic acid). 47 For this study, we focus on the neutral oligosaccharides elucidation, as the method for anionic analysis differs significantly. Anionic structures will be the focus of a future publication.
HPLC-Chip/TOF MS Analysis. HPLC separation with PGC provides a robust and reproducible method for separation of oligosaccharides. 27, 48, 49 In this research, HPLC-Chip/TOF MS is used for the nano-LC separation of the OS with the PGC stationary phase packed into microchip columns. We have previously shown that the HPLC-Chip/TOF MS yields high retention time reproducibility and effective separation of oligosaccharide isomers. 27 To simplify the chromatogram, HMOs are reduced to eliminate the ambiguity due to the separation of anomers under the HPLC conditions. Figure 2a shows the base peak chromatogram (BPC) of the HMOs from a pooled sample collected from five donors. Nineteen standard milk OS were obtained from commercial sources and analyzed with the HPLC-Chip/TOF MS. Figure 2b shows the BPC for a mixture consisting of eight commercially obtained standards labeled with the corresponding compound name. Isomers eluted from nano-LC typically have different retention times. OS that overlap in nano-LC separation were mostly of different masses. Figure 2c is the extracted ion chromatogram (EIC) for isomers with the neutral mass 1585.6 (m/z 793.8 doubly charged, MS inset). The EIC and deconvoluted data showed seven different isomers with their retention Table 1 ). The reproducibility of the retention times from Chip-LC and the accurate mass from the high performance TOF MS provide a sensitive and efficient method for identifying oligosaccharide structures. By matching the RT against the standard OS (Figure 2a and b) , 19 neutral OS structures were determined in this manner from the pooled sample directly. The most abundant OS in the pooled sample correspond to lacto-N-tetraose (LNT) (m/z 710.3, RT 15.1 min) and lacto-Nfucopentaose I (LNFP I) (m/z 856.3, RT 14.6 min). High mass accuracy was obtained by using a dual ESI source assembly, which provides continuous calibration and guarantees high mass accuracy during the entire process. All HMOs found by HPLC-Chip/TOF MS analysis are listed in Supplementary Table  1 with their accurate masses, retention times, monosaccharide compositions and relative abundances all assigned. Over 200 oligosaccharides were found, consistent with our previous report.
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Characterization of Unknown HMO Structures by Tandem MS. To characterize unknown structures, the pooled sample was first separated using standard off-line HPLC into smaller sample pools. From the HPLC separation, 80 fractions were collected and analyzed by MALDI FTICR as discussed in the methods section. Less than half, or 34 fractions, were found to have OS. Each fraction was further analyzed by HPLC-Chip/ TOF MS to determine the number of isomers in each fraction.
The HPLC fractions allow the tandem MS and exoglycosidase examination of enriched components. Structural information was obtained by tandem MS (IRMPD or CID). The sequence and connectivity of the saccharide residues are readily determined. The tandem MS data of the 19 HMO standards were used to obtain the characteristic fragmentation behavior of the OS. Isomers with, for example, different branching arrangements will have different fragmentation pathways that generate unique diagnostic peaks. Diagnostic peaks provide structural information, like fingerprints, that when combined allow structural elucidation of the compound.
Supplementary Figure 3 shows the tandem MS (employing IRMPD in the FTICR-MS) for two LNFP isomers in the positive mode. Both spectra have a y type ion 50 [3Hex + 1HexNAc + Na]
+ (m/z 732.3) due to the loss of the fucose. LNFP II can generate a b type ion [2Hex + 1HexNAc + 1Fuc + Na] + (m/z 696.2) due to the loss of glucose on the reducing end and the sequential loss of a Hex to form [1Hex + 1HexNAc + 1Fuc + Na]
+ (m/z 534.2). However, in LNFP V these two ions are not found since the fucosylation is on the reducing end, and there Figure 4b ). The two ions were examined by IRMPD, which also confirmed their monosaccharide composition ( Figure 5 ). By searching the diagnostic peaks and comparing the fragmentation pattern with standard OS, m/z 1243.4 was determined to have a branched structure. From the published structures, only three have branched structures with this composition, namely, MFLNH I, MFLNH III, and MFLNnH (Figure 5a ). MFLNH III is available as a standard with retention time at 17.3 min. The possible structures for this isomer was narrowed from eight possible isomers to two branched chain isomers, MFLNH I and MFLNnH. However, the possibility of a yet unknown structure cannot be dismissed at this time.
Employing the same method, m/z 1389.5 was also determined to have a branched structure (Figure 5b) . The two species m/z 1389.5 and m/z 1243.4 differed only by a fucose but had very similar fragmentation patterns. The possible structures for m/z 1389.5 can also be narrowed from six isomers to three branched isomers, DFLNHa, DFLNHc, and DFLNnH.
Employment of Exoglycosidase Reactions for Structural
Elucidation. The tandem MS spectra of reduced HMOs in the positive mode yielded b, y or c, z type ions 50 with little or no cross-ring fragments (a and x ions). The linkages between monosaccharides cannot be determined by tandem MS alone. Exoglycosidase digestion can however selectively cleave monosaccharides from the nonreducing end, because exoglycosidases are highly specific for the linkages (including the anomeric character) and the monosaccharides. 51 By using the various exoglycosidases in a strategic manner while employing MALDI MS to monitor the products, the linkages between monosaccharides can be determined. However, the reaction time is of some importance as the specificity decreases when the reaction is allowed to continue for too long. Nonetheless, under the right conditions the reaction is highly specific and will not cleave other linkages or other saccharide residues. Since different enzymes will retain activity and specificity even when other enzymes are present, different enzymes can be added stepwise without removal while the reaction is monitored by mass spectrometry. In so doing, the complete structure can be elucidated by combining the results from the MS, the tandem MS, and the exoglycosidase digestion. Figure 6 is the sequential exoglycosidase digestion of HPLC fraction 21 by R(1-2) fucosidase and (1-3) galactosidase, respectively. Figure 6a Fuc(R1-2) and a free Gal( 1-3), which corresponds well to DFLNHa (inset structure in Figure 6c ).
To confirm further that the structure of m/z 1389.5 is DFLNHa and determine the structure of m/z 1243.4, more digestion experiments were performed. For clarity, Figure 6a is duplicated in Figure 7a + by losing the reducing end. Therefore, the species m/z 1243.4 is shown to be a new structure annotated in Figure 7a with a Lewis a epitope and not MFLNnH
Conclusions
The library of neutral HMOs is presented in Table 2 . It includes 45 structures, with 13 that are new. The larger oligosaccharides are typically highly fucosylated and are often difficult to elucidate completely. In some cases, partial structures are provided when the entire structure cannot be fully elucidated. This library includes structures, accurate masses, and LC retention times. This library provides a valuable template for the rapid identification of HMOs structures. We can now identify any compound in the library from biological samples by simply comparing their retention times and accurate masses to the database.
Examination of the neutral HMO structures generated a few general linkage rules that may be useful for studying the biosynthesis of HMOs (Supplementary Figure 5) . The most general observation is that all fucoses are linked R and all other residues are linked . The other observations are HMOs contain a number of Lewis epitopes including Lewis a, b, x, and y. From the pooled sample we can make some general conclusions regarding the relative abundances of each epitope. Lewis a (8-13%) and Lewis x (10-15%) are about equally abundant and more abundant than Lewis b and y. Lewis b (4-8%) is found to be more abundant than Lewis y (1-3%) (Supplementary Table 2 ). This observation is consistent with the proposed biosynthetic pathway (pathways in Supplementary Figure 5 ). Lewis b is formed from both Lewis a and the type I H antigen, whereas Lewis y can only come from Lewis x.
Finally, the larger oligosaccharide structures such as TFLNH and 6340b (Table 2) offer some intriguing characteristics like the presence of multiple epitopes. Multiple epitopes may enhance the activity of these compounds. Elucidating their structures offer a greater challenge, although a recent report by Amano et al. 73 described strategies to access them. 
